Search
WAVE Life Sciences Ltd
WVEAdd to Watchlist
3.130USD
-0.025-0.79%
Close 11-13 16:00（ET）
617.33MMarket Cap
LossP/E TTM
WAVE Life Sciences Ltd (WVE) Stock Price Target & Forecast
Analyst Rating
Based on 20 analysts giving stock ratings to WAVE Life Sciences Ltd in the past month.
Buy
7 Strong Buy
12 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
18.316USD+410.19%
WVE Analyst Recommendation Trends
In the current month, WVE has received 12 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. WVE average Analyst price target in the last month is 18.316.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
7
7
5
5
5
5
5
5
12
12
11
11
11
11
11
11
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
20
16
16
16
16
16
16
WVE Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, WVE EPS is projected to reach -0.333 in FY2026Q4, following reported EPS of -0.303 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.33
-0.31
-0.33
-0.33
-0.35
Actual
-0.13
-0.34
-0.30
--
--
Surprise
+60.25%
-10.02%
+9.11%
--
--
FAQs
What is WAVE Life Sciences Ltd's expected revenue for the next quarter?
WAVE Life Sciences Ltd's expected revenue is 6.82M.
What is WAVE Life Sciences Ltd's price target?
Analysts forecast that WAVE Life Sciences Ltd's price target is USD 18.26, with the highest forecast at USD 44.00 and the lowest forecast at USD 10.00.
How have WAVE Life Sciences LtdWVE's recent earnings per share performed?
The market expectation was USD -0.30, while WAVE Life Sciences LtdWVE's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.33.
What is the analyst rating for WAVE Life Sciences Ltd?
Based on the ratings of WAVE Life Sciences Ltd's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.